TCMT at MassChallenge 2023

TCMT is excited to announce that we have been invited to participate in MassChallenge 2023!!! Week 1 is already in the books with so much great information. Looking forward to see what week 2 offers and connecting with our MassChallenge mentor.

It is truly an honor to be part of the MassChallenge Community as we continue to make progress in bring to market our first product D’VIA™️. D’VIA™️ is the first 4-in-1 Dual Chamber Blood Collection System that prevents expensive false-positive, false-negatives and process contamination by isolating pure, uncontaminated blood for accurate sepsis testing and diagnosis.

MassChallenge has invited True Concepts Medical Technologies among 186 #startups to participate in the 2023 U.S. Early Stage Program. I’m looking forward to seeing the innovations from all over the world from this year’s cohorts! Meet the Cohorts: https://hubs.li/Q01SWpXR0
🎉 50% of startups have at least 1 #BIPOC founder
👏 40% of startups have at least 1 female or #nonbinary founder
We’ll benefit from:
📈 LEANSTACK Training that will help the cohorts find repeatable and scalable business models
🤝 40+ global #CorporatePartners including IBM, BAE Systems, Carta, Fundify, First Republic, and more
💵 Opportunities to win non-dilutive cash prizes and other in-kind awards, and more
Congratulations everyone! #MC23